Supraclavicular brachial plexus block combined intra-fascial injection of ropivacaine and supraclavicular brachial plexus block comparison: a randomized controlled study

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2400087808

Enrollment

Unknown

Registered

2024-08-05

Start date

2024-08-15

Completion date

Unknown

Last updated

2024-08-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain

Interventions

Experimental group :Supraclavicular brachial plexus block combined with intrafascial injection of ropivacaine

Control group :Supraclavicular brachial plexus block

Eligibility

Sex/Gender

All

Age

18 Years to 64 Years

Inclusion criteria

Inclusion criteria: Aged from 18 to 64, whether male or female, and meeting the standards for the American Society of Anesthesiologists (ASA) grade I to II.

Exclusion criteria

Exclusion criteria: Refusal to participate in the study, pregnancy and lactation, history of allergy to local anesthetics, neurological and psychiatric disorders, history of diabetes, coagulopathy, history of alcohol abuse, communication disorders, use of opioids or nonsteroidal drugs within 2 weeks, poor diffusion of local anesthetics.

Design outcomes

Primary

Measure	Time frame
The brachial plexus nerve controls sensation in the area;The brachial plexus controls movement in the area;	—

Countries

China

Contacts

Public ContactXuan Qinghang

The First Affiliated Hospital of Dali University

xuanqinghang@163.com+86 152 5306 6603

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026